Study: Cannabis legalization leads to lower suicide rates
Recent research by experts from the Case Western Reserve University School of Medicine, the Yale Law School, from Cato Institute and Reason Foundation, found no correlation between cannabis use, suicide and mental illness.
It follows a 2013 study that reached the same conclusion, namely that legalizing recreational cannabis correlated with a 6.29 % reduction in suicide rates among men aged 40-49, and that no other mental health outcomes were systematically affected by cannabis liberalization, according to the researchers.
The new study uses the same methodology as the 2013 study, performing a longitudinal analysis at the state level using suicide rates from the National Center for Health Statistics and mental health morbidity rates in the National Survey on Drug Use and Health. Data included all 50 states and Washington, D.C., from 1999 to 2019.
The new study notes, «Negative mental health outcomes do not follow state-level cannabis liberalization, confirming the findings [of the 2013 study]. In addition, there is evidence that access to recreational marijuana reduces suicide rates among middle-aged men.»
They note that, although suicide rates reached higher levels in all ETats, they declined for «certain demographic categories» after access to recreational cannabis. Although, at the same time, cannabis use, after reaching an all-time low in 1992, showed a slight upward trend until 2007 and, since then, has also increased at a higher rate until 2019.
They also note that Anderson et al. found (in the 2013 study) that legalizing medical marijuana resulted in a 10.8 % and 9.4 % drop in suicide rates for men aged 20-29 and 30-39 respectively.
In conclusion, the researchers say that concerns about the correlation between cannabis use and depression should not interfere with state or federal efforts to decriminalize or legalize cannabis.
«In fact, legalization will have the salutary effect of enabling more rigorous research - now inhibited by federal prohibition - into the additional benefits, as well as any other potential harms, of long-term marijuana use, and promoting safer use,» the researchers concluded.
-
Cannabis in France4 weeks ago
France Sets July as the Deadline for the Widespread Adoption of Medical Cannabis
-
Cannabis in Europe2 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France2 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.2 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Cannabis in Ireland3 weeks ago
The Irish Parliament recommends decriminalizing all drugs
-
Business4 weeks ago
Sanity Group is expanding its presence in Switzerland through a distribution agreement with Astrasana
-
Cannabis in France4 weeks ago
Medical Cannabis in France: What the First Major Study Reveals About Its Actual Impact
-
Cannabis in Switzerland3 weeks ago
St. Gallen, Switzerland, Launches Its 8th Legal Cannabis Pilot Project


You must be logged in to post a comment Login